Literature DB >> 6222712

Effects of prostacyclin infusion on platelet activation and postoperative blood loss in coronary bypass.

C Aren, K Feddersen, K Rådegran.   

Abstract

The effects of infusion of prostacyclin were studied in 41 patients undergoing aortocoronary bypass. Twenty-three patients received heparin (2 mg per kilogram of body weight) and prostacyclin (50 ng per kilogram per minute) during cardiopulmonary bypass (CPB). Eighteen patients received heparin (3 mg per kilogram). One hour after CPB, the platelet count was 98 +/- 16% of the value obtained before CPB in the prostacyclin group and 73 +/- 18% in the control group (p less than 0.001). The plasma level of platelet factor 4 rose only initially during CPB in the prostacyclin group, but increased continuously in the control group; at 90 minutes of CPB it was 92 +/- 35 ng per milliliter and 376 +/- 119 ng per milliliter, respectively (p less than 0.001). Beta-thromboglobulin showed a similar pattern. Postoperative chest drainage was 386 +/- 87 ml in the prostacyclin group and 596 +/- 342 ml in the control group (p less than 0.05). Blood transfused during and five days after operation was 1,359 +/- 751 ml in the prostacyclin group and 2,047 +/- 915 ml in the control group (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6222712     DOI: 10.1016/s0003-4975(10)60648-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Pulmonary and haemodynamic effects of extracorporeal circulation in the cat and the beneficial effects of prostacyclin.

Authors:  J Jahr; P O Grände
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Abnormal platelet aggregation in pediatric pulmonary hypertension.

Authors:  Stephanie S Handler; Jing Jin; Michelle T Ogawa; Jeffrey A Feinstein; Clara Lo
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

3.  Pathophysiology of brain damage during open-heart surgery.

Authors:  K M Taylor
Journal:  Tex Heart Inst J       Date:  1986-03

4.  A prospective study of the clinical benefits of prostacyclin in 554 cardiopulmonary bypass procedures.

Authors:  M Merli; B Amari; C Cattani; L Villa; M M Visigalli; A Pellegrini
Journal:  Tex Heart Inst J       Date:  1988

5.  Effect of prostacyclin on vascular capacity in the dog.

Authors:  T G Fulghum; J P DiMarco; E W Supple; I Nash; J Gendlerman; D F Eton; J B Newell; R M Zusman; W J Powell
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.